Acadia Pharma (ACAD) Misses Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $29.01 +2.73%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.61), $0.05 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $2.9 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
